Search

A Phase 2 Safety and Tolerability Study to Investigate the Effect of AZD5213 on Sleep

Therapeutic area :

Hannesdottir K., Minkwitz M., Raudibaugh K., Vis P., Ackaert O. and Alexander R. A Phase 2 Safety and Tolerability Study to Investigate the Effect of AZD5213 on Sleep in Subjects with Mild Cognitive Impairment and Mild Alzheimer’s Disease. AAIC (2013)

Our expertise

Lung Diseases General modelling Anesthesiology Blood disorders Biologicals Safety pharmacology Anti-infectives and immunology Diabetes Gastrointestinal Diseases Cardiovascular Methods Pain Paediatrics Peripheral Nervous System Endocrinology/Sexual health Oncology CNS